findmyKOL

Valerie Callender, MD

Enriched profile

Professor of Dermatology, Howard University College of Medicine; Founder & Medical Director, Callender Dermatology & Cosmetic Center · Callender Dermatology & Cosmetic Center

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Glenn Dale, MD · Northeast · United StatesSpecialtyDermatologyFocusAcne / Hidradenitis
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Valerie Callender is Professor of Dermatology, Howard University College of Medicine; Founder & Medical Director, Callender Dermatology & Cosmetic Center at Callender Dermatology & Cosmetic Center. OpenAlex indexes 192 publications with 4,242 citations (h-index 35); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 15 Oct 2026

Valerie Callender, MD, is Professor of Dermatology, Howard University College of Medicine at Callender Dermatology & Cosmetic Center. The public record shows 192 publications with 4,242 citations (h-index 35), centered on Acne / Hidradenitis. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 43 companies.

  • Most recent indexed publication: 2026 · Journal of cosmetic dermatology
  • Top research focus: Acne / Hidradenitis
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 43 companies

Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Melanosis1 trialAlopecia1 trialAcne / Hidradenitis1 trialAcne Vulgaris1 trial

Research focus

OpenAlex concept fingerprint
Acne / Hidradenitis

Drugs & molecules

across trials, industry payments and publications
Eucrisageneric · CrisaboroleClinical trials—Industry payments28Publications1Cibinqogeneric · AbrocitinibClinical trials—Industry payments33Publications—Vtamageneric · TapinarofClinical trials—Industry payments31Publications—Akliefgeneric · TrifaroteneClinical trials—Industry payments20Publications—Dupixentgeneric · DupilumabClinical trials—Industry payments19Publications—Litfulogeneric · RitlecitinibClinical trials—Industry payments19Publications—Zoryvegeneric · RoflumilastClinical trials—Industry payments18Publications—Skyrizigeneric · RisankizumabClinical trials—Industry payments14Publications—Rinvoqgeneric · UpadacitinibClinical trials—Industry payments13Publications—MINOLIRA EXTENDED RELEASEClinical trials—Industry payments12Publications—Adbrygeneric · TralokinumabClinical trials—Industry payments10Publications—Amzeeqgeneric · MinocyclineClinical trials—Industry payments9Publications—

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trials—Industry payments59Pfizer Inc.Clinical trials—Industry payments43Galderma Laboratories, L.P.Clinical trials—Industry payments36Arcutis Biotherapeutics, Inc.Clinical trials—Industry payments31Dermavant Sciences, Inc.Clinical trials—Industry payments29Allergan, Inc.Clinical trials—Industry payments21Lilly USA, LLCClinical trials—Industry payments15Mayne Pharma Inc.Clinical trials—Industry payments15Ortho Dermatologics, a division of Bausch Health US, LLCClinical trials—Industry payments15LEO Pharma Inc.Clinical trials—Industry payments14Genzyme CorporationClinical trials—Industry payments12Medimetriks Pharmaceuticals, Inc.Clinical trials—Industry payments12Incyte CorporationClinical trials—Industry payments10Janssen Biotech, Inc.Clinical trials—Industry payments10EPI Health, LLCClinical trials—Industry payments8UCB, Inc.Clinical trials—Industry payments8Amgen Inc.Clinical trials—Industry payments7Sun Pharmaceutical Industries Inc.Clinical trials—Industry payments7VYNE Pharmaceuticals Inc.Clinical trials—Industry payments7Journey Medical CorporationClinical trials—Industry payments6Organon LLCClinical trials—Industry payments6Almirall LLCClinical trials—Industry payments5E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments5Eli Lilly and CompanyClinical trials—Industry payments4Revance Therapeutics, Inc.Clinical trials—Industry payments4Callender Center for Clinical ResearchClinical trials3Industry payments—Kowa Pharmaceuticals America, Inc.Clinical trials—Industry payments3Novartis Pharmaceuticals CorporationClinical trials—Industry payments3Avita Medical Americas, LLCClinical trials—Industry payments2Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments2

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
192publications

Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.

4,242citations

Total citations across indexed works.

35h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials ↓
43companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Public positions

sourced statements on record

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 15 Oct 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 15 Oct 2026

43 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    71.8%
    Corticosteroid68.8%
    Triamcinolone acetonide83%Triamcinolone Acetonide10%Fluocinolone Acetonide7%
    Part D + Part B≥160 patients
    Other antifungals for topical use3%
    Ciclopirox100%
    Part D≥16 patients
  • Cardiovascular

    9.3%
    Corticosteroid6.2%
    Fluocinonide100%
    Part D≥39 patients
    Arteriolar Vasodilator1.9%
    Minoxidil100%
    Part D<11 patients

    + 1 more class in this area

  • Anti-infectives

    6.7%
    Azole Antifungal4%
    Ketoconazole100%
    Part D≥22 patients
    Tetracycline-class Drug2.7%
    Doxycycline Hyclate100%
    Part D≥17 patients
All 7 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 15 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 15 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Facebook

    facebook.com/Dr-Valerie-Callender-1661979197245210

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • Instagram

    instagram.com/callenderskin

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
  • X / Twitter

    twitter.com/drcallender

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →twitter.com ↗
  • LinkedIn

    linkedin.com/in/valerie-callender-md-7b538269

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

Mentions by others

where others cite or feature them
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 15 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Howard University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →callenderskin.com ↗
  • FAAD - Fellow

    American Academy of Dermatology (Board-Certified in Dermatology)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →callenderskin.com ↗

Editorial & leadership roles

journal and society appointments
  • President

    American Dermatological Association

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →callenderskin.com ↗
  • Current President

    American Acne & Rosacea Society

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →skinofcolorsociety.org ↗
  • Past President

    Women's Dermatologic Society

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →callenderskin.com ↗
  • Past President

    Skin of Color Society; Co-Chair, Meeting the Challenge in Research Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →skinofcolorsociety.org ↗
  • Board of Directors member

    American Academy of Dermatology (former Executive Committee member)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →callenderskin.com ↗
  • Founder and Principal Investigator

    Callender Center for Clinical Research

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →callenderskin.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.